American Portfolios Advisors’s Bionano Genomics BNGO Stock Holding History

American Portfolios Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$5.36K	Hold	5	–	–	﹤0.01%	2794
2022 Q2	$4.04K	Sell	5 -2	-29%	-$2.06K	﹤0.01%	2918
2022 Q1	$10.8K	Hold	7	–	–	﹤0.01%	2656
2021 Q4	$12.5K	Buy	7 +2	+40%	+$5.35K	﹤0.01%	2534
2021 Q3	$17.6K	Hold	5	–	–	﹤0.01%	2341
2021 Q2	$22K	Buy	5 +2	+67%	+$7.9K	﹤0.01%	2179
2021 Q1	$12.9K	Sell	3 -1	-25%	-$5.64K	﹤0.01%	2268
2020 Q4	$7.7K	Buy	+4	New	+$1.5K	﹤0.01%	2234

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

American Portfolios Advisors's BNGO Position: Q3 2022 in Review

American Portfolios Advisors held its Bionano Genomics (BNGO) position steady in Q3 2022 at 5 shares worth $5.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2794.

American Portfolios Advisors first reported a position in BNGO in Q4 2020 and has held it in 8 quarters since. The position peaked at $22K in Q2 2021. 140 funds tracked by Wall St. Rank hold BNGO as of Q3 2022.

American Portfolios Advisors held 5 shares of Bionano Genomics worth $5.36K as of Q3 2022.
American Portfolios Advisors left its Bionano Genomics share count unchanged in Q3 2022.
Bionano Genomics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #2794 holding.
American Portfolios Advisors first reported a position in Bionano Genomics in Q4 2020 and has held it in 8 quarters since.
American Portfolios Advisors's Bionano Genomics position peaked at $22K in Q2 2021.
140 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.